Decman

Vilma Decman is an accomplished leader currently serving as the Executive Director and Head of Cellular Biomarkers at GSK, where they lead teams in clinical and translational biomarker testing using advanced technologies. With extensive experience in immunology and clinical research, Vilma has held key positions at notable organizations, including Bristol-Myers Squibb and Regeneron Pharmaceuticals. They completed their PhD in Immunology at the University of Pittsburgh and also hold a Business Essentials Certificate from The Wharton School. Throughout their career, Vilma has actively engaged in mentoring and talent development, contributing significantly to the field of biomarker discovery and validation.